Home » FDA Panel Meeting for Nymox PMA Application Expected in July
FDA Panel Meeting for Nymox PMA Application Expected in July
Nymox Pharmaceutical announced that it has been informed that the company's premarket approval (PMA) application to FDA concerning a kit version of the company's AlzheimAlert urine test will be going forward to a presentation before a panel of the Medical Devices Advisory Committee which is expected in July. This step follows the submission to the FDA of further data and analyses by the company.
()a href="http://www.genengnews.com/news/bnitem.aspx?name=536609XSL_NEWSML_TO_NEWSML_WEB.xml" target="_blank">Genetic Engineering News
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
07May
-
14May
-
30May